Medicine and Dentistry
Cardiovascular Risk
100%
Glucagon Like Peptide 1
100%
Gastric Inhibitory Polypeptide
100%
Ghrelin
100%
Side Effect
66%
Body Mass Index
66%
Proinsulin
66%
Leptin
66%
Hemoglobin A1c
66%
Diabetes Mellitus
66%
Adiponectin
66%
C-Peptide
66%
Typical Antipsychotic
66%
Glucagon
66%
Pathophysiology
33%
Tumor Necrosis Factor
33%
C Reactive Protein
33%
Interleukin 6
33%
Meal
33%
Ingestion
33%
Beta Cell
33%
Cross Sectional Study
33%
Glycated Hemoglobin
33%
Glucose Metabolism
33%
Dyslipidemia
33%
Obesity
33%
Plasminogen Activator Inhibitor-1
33%
Keyphrases
Antipsychotics
100%
Cardiovascular Risk Markers
100%
Ghrelin
50%
Glucagon-like
50%
Waist Circumference
50%
Glucose-dependent Insulinotropic Polypeptide
50%
Plasma Parameters
33%
Body Mass Index
33%
Adiponectin
33%
Insulin
33%
Leptin
33%
Non-diabetic
33%
Glucagon
33%
Proinsulin C-peptide
33%
Metabolic Side Effects
33%
C-reactive Protein
16%
Pathophysiology
16%
Interleukin-6
16%
Tumor Necrosis Factor-α
16%
Healthy Controls
16%
Psychiatric Practice
16%
Male Patients
16%
Hemoglobin A1c (HbA1c)
16%
Healthy Males
16%
Between-group
16%
B Cells
16%
Pathophysiological Mechanisms
16%
Insulin Resistance
16%
Glucose Metabolism
16%
Dyslipidemia
16%
Plasminogen Activator inhibitor-1 (PAI-1)
16%
Cardiovascular Risk Profile
16%
Male Control
16%
Fasted State
16%
Glycated Hemoglobin A1c
16%
Hypersecretion
16%
Liquid Meal
16%
Glucose Level
16%
Dysmetabolism
16%
Clinical Insight
16%
Appetite Hormones
16%
Metabolic Screening
16%
Elevated Glucose
16%